These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 22498205)

  • 1. Prostate cancer foci detected on multiparametric magnetic resonance imaging are histologically distinct from those not detected.
    Rosenkrantz AB; Mendrinos S; Babb JS; Taneja SS
    J Urol; 2012 Jun; 187(6):2032-8. PubMed ID: 22498205
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor target volume for focal therapy of prostate cancer-does multiparametric magnetic resonance imaging allow for a reliable estimation?
    Cornud F; Khoury G; Bouazza N; Beuvon F; Peyromaure M; Flam T; Zerbib M; Legmann P; Delongchamps NB
    J Urol; 2014 May; 191(5):1272-9. PubMed ID: 24333516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diffusion-weighted and dynamic contrast-enhanced MRI of prostate cancer: correlation of quantitative MR parameters with Gleason score and tumor angiogenesis.
    Oto A; Yang C; Kayhan A; Tretiakova M; Antic T; Schmid-Tannwald C; Eggener S; Karczmar GS; Stadler WM
    AJR Am J Roentgenol; 2011 Dec; 197(6):1382-90. PubMed ID: 22109293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictors of unfavorable disease after radical prostatectomy in patients at low risk by D'Amico criteria: role of multiparametric magnetic resonance imaging.
    Song SH; Pak S; Park S; Song C; Jeong IG; Choi HJ; Kim JK; Cho KS; Kim CS; Ahn H
    J Urol; 2014 Aug; 192(2):402-8. PubMed ID: 24631106
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histopathological differences between prostate cancer foci that are detected and missed using multiparametric magnetic resonance imaging in Korean patients.
    Chung JD; Lee JB; Lee TJ; Kwon JK; Kim JH; Chang IH; Do Kim K
    Int J Urol; 2014 May; 21(5):466-72. PubMed ID: 24877252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High diagnostic ability of multiparametric magnetic resonance imaging to detect anterior prostate cancer missed by transrectal 12-core biopsy.
    Komai Y; Numao N; Yoshida S; Matsuoka Y; Nakanishi Y; Ishii C; Koga F; Saito K; Masuda H; Fujii Y; Kawakami S; Kihara K
    J Urol; 2013 Sep; 190(3):867-73. PubMed ID: 23542406
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-risk prostate cancer: the accuracy of multiparametric MR imaging for detection.
    Kim JY; Kim SH; Kim YH; Lee HJ; Kim MJ; Choi MS
    Radiology; 2014 May; 271(2):435-44. PubMed ID: 24484061
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dynamic contrast enhanced, pelvic phased array magnetic resonance imaging of localized prostate cancer for predicting tumor volume: correlation with radical prostatectomy findings.
    Villers A; Puech P; Mouton D; Leroy X; Ballereau C; Lemaitre L
    J Urol; 2006 Dec; 176(6 Pt 1):2432-7. PubMed ID: 17085122
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiparametric magnetic resonance imaging for the detection and localization of prostate cancer: combination of T2-weighted, dynamic contrast-enhanced and diffusion-weighted imaging.
    Delongchamps NB; Rouanne M; Flam T; Beuvon F; Liberatore M; Zerbib M; Cornud F
    BJU Int; 2011 May; 107(9):1411-8. PubMed ID: 21044250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low-risk prostate cancer patients without visible tumor (T1c) on multiparametric MRI could qualify for active surveillance candidate even if they did not meet inclusion criteria of active surveillance protocol.
    Lee DH; Koo KC; Lee SH; Rha KH; Choi YD; Hong SJ; Chung BH
    Jpn J Clin Oncol; 2013 May; 43(5):553-8. PubMed ID: 23580758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peripheral zone prostate cancer localization by multiparametric magnetic resonance at 3 T: unbiased cancer identification by matching to histopathology.
    Selnæs KM; Heerschap A; Jensen LR; Tessem MB; Schweder GJ; Goa PE; Viset T; Angelsen A; Gribbestad IS
    Invest Radiol; 2012 Nov; 47(11):624-33. PubMed ID: 23011187
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characteristics of Detected and Missed Prostate Cancer Foci on 3-T Multiparametric MRI Using an Endorectal Coil Correlated With Whole-Mount Thin-Section Histopathology.
    Tan N; Margolis DJ; Lu DY; King KG; Huang J; Reiter RE; Raman SS
    AJR Am J Roentgenol; 2015 Jul; 205(1):W87-92. PubMed ID: 26102423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ability of preoperative 3.0-Tesla magnetic resonance imaging to predict the absence of side-specific extracapsular extension of prostate cancer.
    Hara T; Nakanishi H; Nakagawa T; Komiyama M; Kawahara T; Manabe T; Miyake M; Arai E; Kanai Y; Fujimoto H
    Int J Urol; 2013 Oct; 20(10):993-9. PubMed ID: 23360237
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multifocality and prostate cancer detection by multiparametric magnetic resonance imaging: correlation with whole-mount histopathology.
    Le JD; Tan N; Shkolyar E; Lu DY; Kwan L; Marks LS; Huang J; Margolis DJ; Raman SS; Reiter RE
    Eur Urol; 2015 Mar; 67(3):569-76. PubMed ID: 25257029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How accurate is multiparametric MR imaging in evaluation of prostate cancer volume?
    Bratan F; Melodelima C; Souchon R; Hoang Dinh A; Mège-Lechevallier F; Crouzet S; Colombel M; Gelet A; Rouvière O
    Radiology; 2015 Apr; 275(1):144-54. PubMed ID: 25423145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostate cancer detection by prebiopsy 3.0-Tesla magnetic resonance imaging.
    Nishida S; Kinoshita H; Mishima T; Kurokawa H; Sakaida N; Matsuda T
    Int J Urol; 2011 Sep; 18(9):653-8. PubMed ID: 21790792
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prostate cancer: comparison of tumor visibility on trace diffusion-weighted images and the apparent diffusion coefficient map.
    Rosenkrantz AB; Kong X; Niver BE; Berkman DS; Melamed J; Babb JS; Taneja SS
    AJR Am J Roentgenol; 2011 Jan; 196(1):123-9. PubMed ID: 21178056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of biologic aggressiveness of prostate cancer: correlation of MR signal intensity with Gleason grade after radical prostatectomy.
    Wang L; Mazaheri Y; Zhang J; Ishill NM; Kuroiwa K; Hricak H
    Radiology; 2008 Jan; 246(1):168-76. PubMed ID: 18024440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiparametric MRI is helpful to predict tumor focality, stage, and size in patients diagnosed with unilateral low-risk prostate cancer.
    Delongchamps NB; Beuvon F; Eiss D; Flam T; Muradyan N; Zerbib M; Peyromaure M; Cornud F
    Prostate Cancer Prostatic Dis; 2011 Sep; 14(3):232-7. PubMed ID: 21423266
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostate cancer: Comparison of 3D T2-weighted with conventional 2D T2-weighted imaging for image quality and tumor detection.
    Rosenkrantz AB; Neil J; Kong X; Melamed J; Babb JS; Taneja SS; Taouli B
    AJR Am J Roentgenol; 2010 Feb; 194(2):446-52. PubMed ID: 20093608
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.